Highly active antiretroviral therapy (HAART) modifies the incidence and outcome of visceral leishmaniasis in HIV-infected patients

J Acquir Immune Defic Syndr. 2002 Jul 1;30(3):364-6. doi: 10.1097/00126334-200207010-00015.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiretroviral Therapy, Highly Active*
  • CD4 Lymphocyte Count
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • Humans
  • Incidence
  • Leishmaniasis, Visceral / epidemiology*